Skip to main content
SpringerLink
Log in

Nitric Oxide Modulated the Expression of DREAM/Calsenilin/KChIP3 in Inflammatory Pain of Rats

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Downstream regulatory element antagonistic modulator (DREAM) is a critical transcriptional repressor for pain modulation. The role of nitric oxide (NO) plays in modulating DREAM pain pathway in the periphery is unclear. Therefore, we investigated the role of the NO in modulation of the expression of DREAM in formalin-induced rat inflammatory pain models. Male Sprague-Dawley rats were randomly distributed into four groups: the normal group, formalin test group, Nω-nitro-l-arginine (l-NNA) group, and morphine group. One hundred microliters of 2.5 % formalin was injected into the plantar surface of the right hindpaw of rats. l-NNA (40 nmol/L) and morphine (40 nmol/L) were injected intrathecally in the hindpaw before formalin injection. The nociceptive behavioral reaction was recorded. After the formalin test, the expression of DREAM mRNA and protein in the spinal cord of the four groups were measured. The nociceptive reaction induced by injection of formalin exhibited two phases. Morphine and l-NNA significantly decreased pain scores of the second phase. The expression of DREAM was significantly increased in the rat spinal cord after formalin-induced pain. Morphine significantly upregulated the expression of DREAM, and the formalin-induced upregulation was significantly attenuated by l-NNA. NO may play an important role in the DREAM pathway modulation of inflammatory pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Buxbaum, J.D. 2004. A role for calsenilin and related proteins in multiple aspects of neuronal function. Biochemical and Biophysical Research Communications 322: 1140–1144.

    Article  PubMed  CAS  Google Scholar 

  2. Costigan, M., and C.J. Woolf. 2002. No DREAM, No pain. Closing the spinal gate. Cell 108: 297–300.

    Article  PubMed  CAS  Google Scholar 

  3. Cheng, H.Y., G.M. Pitcher, S.R. Laviolette, I.Q. Whishaw, K.I. Tong, L.K. Kockeritz, T. Wada, N.A. Joza, M. Crackower, J. Goncalves, I. Sarosi, J.R. Woodgett, A.J. Oliveira-dos-Santos, M. Ikura, D. van der Kooy, M.W. Salter, and J.M. Penninger. 2002. DREAM is a critical transcriptional repressor for pain modulation. Cell 108: 31–43.

    Article  PubMed  CAS  Google Scholar 

  4. Cheng, H.Y., and J.M. Penninger. 2003. When the DREAM is gone: from basic science to future prospectives in pain management and beyond. Expert Opinion on Therapeutic Targets 7: 249–263.

    PubMed  CAS  Google Scholar 

  5. Cury, Y., G. Picolo, V.P. Gutierrez, and S.H. Ferreira. 2011. Pain and analgesia: the dual effect of nitric oxide in the nociceptive system. Nitric Oxide 25: 243–254.

    Article  PubMed  CAS  Google Scholar 

  6. Freire, M.A., J.S. Guimarães, W.G. Leal, and A. Pereira. 2009. Pain modulation by nitric oxide in the spinal cord. Frontiers in Neuroscience 3: 175–181.

    Article  PubMed  CAS  Google Scholar 

  7. Abbott, F.V., K.B.J. Granklin, and R.F. Westbrook. 1995. The formalin test: scoring properties of the first and second phases of pain response in rats. Pain 60: 91–102.

    Article  PubMed  CAS  Google Scholar 

  8. Puig, S., and L.S. Sorkin. 1996. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64: 345–355.

    Article  PubMed  CAS  Google Scholar 

  9. Hao, J.X., and X.J. Xu. 1996. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 66: 313–319.

    Article  PubMed  CAS  Google Scholar 

  10. Meller, S.T., and G.F. Gebhart. 1993. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127–136.

    Article  PubMed  CAS  Google Scholar 

  11. Yamamoto, T., and N. Shimoyama. 1995. Role of nitric oxide in the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat. Anesthesiology 82: 1266–1273.

    Article  PubMed  CAS  Google Scholar 

  12. Sousa, A.M., and W.A. Prado. 2001. The dual effect of a nitric oxide donor in nociception. Brain Research 897: 9–19.

    Article  PubMed  CAS  Google Scholar 

  13. Burgoyne, R.D. 2007. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nature Reviews Neuroscience 8: 182–193.

    Article  PubMed  CAS  Google Scholar 

  14. Craig, T.A., L.M. Benson, S.Y. Venyaminov, E.S. Klimtchuk, Z. Bajzer, F.G. Prendergast, S. Naylor, and R. Kumar. 2002. The metal-binding properties of DREAM: evidence for calcium-mediated changes in DREAM structure. Journal of Biological Chemistry 277: 10955–10966.

    Article  PubMed  CAS  Google Scholar 

  15. Buxbaum, J.D., E.K. Choi, Y. Luo, C. Lilliehook, A.C. Crowley, D.E. Merriam, and W. Wasco. 1998. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nature Medicine 4: 1177–1181.

    Article  PubMed  CAS  Google Scholar 

  16. Campos, D., L. Jiménez-Díaz, and A.M. Carrión. 2003. Ca(2+)-dependent prodynorphin transcriptional derepression in neuroblastoma cells is exerted through DREAM protein activity in a kinase-independent manner. Molecular and Cellular Neuroscience 22: 135–145.

    Article  PubMed  CAS  Google Scholar 

  17. Vallejo, M. 2009. PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis. Molecular Neurobiology 39: 90–100.

    Article  PubMed  CAS  Google Scholar 

  18. Carrión, A.M., W.A. Link, F. Ledo, B. Mellström, and J.R. Naranjo. 1999. DREAM is a Ca2+-regulated transcriptional repressor. Nature 398: 80–84.

    Article  PubMed  Google Scholar 

  19. Jacobson, D.A., J. Cho, L.R. Landa Jr., N.A. Tamarina, M.W. Roe, J.D. Buxbaum, and L.H. Philipson. 2006. Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression. American Journal of Physiology, Endocrinology and Metabolism 291: E587–E595.

    Article  CAS  Google Scholar 

  20. Jin, X.G., S.R. Chen, X.H. Cao, L. Li, and H.L. Pan. 2011. Nitric oxide inhibits nociceptive transmission by differentially regulating glutamate and glycine release to spinal dorsal horn neurons. Journal of Biological Chemistry 286: 33190–33202.

    Article  PubMed  CAS  Google Scholar 

  21. Steinbicker, A.U., H. Liu, K. Jiramongkolchai, R. Malhotra, E.Y. Choe, C.J. Busch, A.R. Graveline, S.M. Kao, Y. Nagasaka, F. Ichinose, E.S. Buys, P. Brouckaert, W.M. Zapol, and K.D. Bloch. 2011. Nitric oxide regulates pulmonary vascular smooth muscle cell expression of the inducible cAMP early repressor gene. Nitric Oxide 25: 294–302.

    Article  PubMed  CAS  Google Scholar 

  22. Roh, D.H., S.R. Choi, S.Y. Yoon, S.Y. Kang, J.Y. Moon, S.G. Kwon, H.J. Han, A.J. Beitz, and J.H. Lee. 2011. Spinal neuronal NOS activation mediates sigma-1 receptor-induced mechanical and thermal hypersensitivity in mice: involvement of PKC-dependent GluN1 phosphorylation. British Journal of Pharmacology 163: 1707–1720.

    Article  PubMed  CAS  Google Scholar 

  23. Matsuda, M., T.A. Yamamoto, and M. Hirata. 2006. Ca2 + -dependent regulation of calcitonin gene expression by the transcriptional repressor DREAM. Endocrinology 147: 4608–4617.

    Article  PubMed  CAS  Google Scholar 

  24. Vogt, B.A. 2002. Knocking out the DREAM to study pain. The New England Journal of Medicine 347: 362–364.

    Article  PubMed  CAS  Google Scholar 

  25. Ledo, F., L. Kremer, B. Mellström, and J.R. Naranjo. 2002. Ca2 + -dependent block of CREB-CBP transcription by repressor DREAM. EMBO Journal 21: 4583–4592.

    Article  PubMed  CAS  Google Scholar 

  26. Cebolla, B., A. Fernández-Pérez, G. Perea, A. Araque, and M. Vallejo. 2008. DREAM mediates cAMP-dependent, Ca2 + -induced stimulation of GFAP gene expression and regulates cortical astrogliogenesis. Journal of Neuroscience 28: 6703–6713.

    Article  PubMed  CAS  Google Scholar 

  27. Pöpping, D.M., N. Elia, E. Marret, M. Wenk, and M.R. Tramèr. 2012. Opioids added to local anesthetics for single-shot intrathecal anesthesia in patients undergoing minor surgery: a meta-analysis of randomized trials. Pain 153: 784–793.

    Article  PubMed  Google Scholar 

  28. Gregori, S.D., M.D. Gregori, G.N. Ranzani, M. Allegri, C. Minella, and M. Regazzi. 2012. Morphine metabolism, transport and brain disposition. Metabolic Brain Disease 27: 1–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Nature and Science Foundation of Heilongjiang Province of People's Republic of China (D201115).

Author information

Authors and Affiliations

  1. Department of Physiology, Harbin Medical University, 194 Xuefu Rd, Nangang District, Harbin, 150081, People’s Republic of China

    Hong-Bo Jin, Ying-Li Song, Yong-Bin Yang & Yu-Rong Li

  2. Center of Experimental Animals, Harbin Medical University, Harbin, 150081, China

    Yong-Liang Yang

Authors
  1. Hong-Bo Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong-Liang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying-Li Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong-Bin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-Rong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu-Rong Li.

Additional information

Hong-Bo Jin and Yong-Liang Yang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, HB., Yang, YL., Song, YL. et al. Nitric Oxide Modulated the Expression of DREAM/Calsenilin/KChIP3 in Inflammatory Pain of Rats. Inflammation 35, 1867–1871 (2012). https://doi.org/10.1007/s10753-012-9508-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9508-8

Key Words

Search

Navigation